Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Phase II Trial of Bendamustine in Combination With Rituximab for Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia. CLL2M Protocol of the German CLL-Study Group (GCLLSG)

NCT00274989 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00274989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Phase II Trial of Bendamustine in Combination With Rituximab for Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia. CLL2M Protocol of the German CLL-Study Group (GCLLSG)
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
March 31, 2011
Enrollment
195 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia